Open AccessAspirin, Nonaspirin Nonsteroidal Anti-inflammatory Drugs, or Acetaminophen and Risk of Ovarian Cancer
Author(s) -
Wei Hsuan Lo-Ciganic,
Janice C. Zgibor,
Clareann H. Bunker,
Kirsten B. Moysich,
Robert P. Edwards,
Roberta B. Ness
Publication year - 2012
Publication title -
epidemiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.901
H-Index - 173
eISSN - 1531-5487
pISSN - 1044-3983
DOI - 10.1097/ede.0b013e3182456ad3
Subject(s) - aspirin , acetaminophen , medicine , odds ratio , confidence interval , ovarian cancer , population , nonsteroidal , cyclooxygenase , pharmacoepidemiology , cancer , anesthesia , pharmacology , medical prescription , biochemistry , chemistry , environmental health , enzyme
Aspirin, nonaspirin nonsteroidal anti-inflammatory drugs (NA-NSAIDs) and acetaminophen all have biologic effects that might reduce the risk of ovarian cancer. However, epidemiologic data on this question are mixed.